KMC Speciality Hospitals (India) Ltd (KMCSHIL) — shareholding pattern, promoter holding, financials and share price
About KMC Speciality Hospitals (India) Ltd (KMCSHIL)
KMC Speciality Hospitals (India) Ltd operates in the Hospital industry, within the Healthcare sector. It trades on the NSE as KMCSHIL and on the BSE under scrip code 524520. Its ISIN is INE879K01018.
Incorporated in 1982, KMC Speciality Hospitals (India) is in the healthcare sector running, operating, maintaining multi-specialty hospital in Trichy. The company belongs to the Kauvery Hospitals group. The Company is primarily engaged in the business of rendering medical and healthcare services.
KMC Speciality Hospitals (India) Limited is a 450-bed multi-specialty hospital operator in Tiruchirappalli, part of the Kauvery Hospitals Group, providing tertiary-care services including mother & child care, neurosciences, gastro sciences, orthopaedics, critical care and organ transplants supported by 1700+ employees and around 170 doctors.
Operational expansion with the new 200-bed Maa Kauvery block has driven utilisation and revenue: Q3 FY'26 total income rose 33% year-on-year to INR 83.2 Cr, occupancy improved to 82%, IP and OP volumes grew strongly, and blended ARPOB increased 17% versus Q3 FY'25, signalling demand capture from the enlarged capacity.
Listed peers in Hospital: Indraprastha Medical Corporation Ltd, Dr Agarwals Eye Hospital Ltd, Shalby Ltd, Unihealth Hospitals Ltd, GPT Healthcare Ltd, Gujarat Kidney & Super Speciality Ltd.
Valuation & Returns
10 Jul 2026At ₹135.05 a share on 10 Jul 2026, KMC Speciality Hospitals (India) Ltd (KMCSHIL) was valued at a price-to-earnings ratio of 47.12x against an industry P/E of 61.73x and a price-to-book of 13.4x on a book value of ₹10.08 per share as of Mar 2025. Solomo computes return on equity of 28.44% and return on capital employed of 28.11% from filed results. Earnings ratios use standalone results for the twelve months Jun 2025 to Mar 2026.
- P/E
- 47.12x
- Industry P/E
- 61.73x
- P/B
- 13.4x
- EPS (TTM)
- ₹2.87
- Book value / share
- ₹10.08
- ROE
- 28.44%
- ROCE
- 28.11%
- ROA
- 16.34%
- Debt / equity
- 0.54x
- Dividend yield
- 0%
- EBITDA margin
- 30.42%
- 52-week range
- ₹62.5 – ₹145.9
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, KMC Speciality Hospitals (India) Ltd (KMCSHIL) reported revenue of ₹306 crore, net profit of ₹47 crore and earnings per share of ₹2.87. That compares with revenue of ₹232 crore and net profit of ₹21 crore in Mar 2025. Figures are standalone, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹82 crore and net profit ₹15 crore (standalone).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 136 | 156 | 177 | 232 | 306 |
| Net profit (₹ cr) | 24 | 27 | 30 | 21 | 47 |
| EPS (₹) | 1.46 | 1.64 | 1.86 | 1.31 | 2.87 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | 20.71% | 19.21% | 19.40% | 30.71% |
| Profit growth | 23.47% | 12.78% | -3.34% | -29.46% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 75% of KMC Speciality Hospitals (India) Ltd (KMCSHIL) (unchanged from the previous quarter), foreign institutional investors (FII) hold 0.02% and domestic institutional investors (DII) hold 0%. Market capitalisation was ₹2,202 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2001.
Largest disclosed public shareholders in Jun 2026: D CHITRA 1.36%, ANITHA S 1.13%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 75% | - | 0.02% | 0% | 25% |
| Mar 2026 | 75% | - | 0% | 0% | 25% |
| Dec 2025 | 75% | - | 0% | 0% | 25% |
| Sep 2025 | 75% | - | 0% | 0% | 25% |
| Jun 2025 | 75% | - | - | 0% | 25% |
| Mar 2025 | 75% | - | 0.01% | 0% | 25% |
| Dec 2024 | 75% | - | - | 0% | 25% |
| Sep 2024 | 75% | - | - | 0% | 25% |